GFACX | VALSX | GFACX / VALSX | |
Total Expense Ratio | 1.36 | 1.14 | 119% |
Annual Report Gross Expense Ratio | 1.36 | 1.14 | 119% |
Fund Existence | 25 years | 69 years | - |
Gain YTD | 17.268 | 0.087 | 19,922% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000 | 25% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 337B | 391M | 86,189% |
Annual Yield % from dividends | 0.00 | 0.09 | - |
Returns for 1 year | 9.41 | -13.63 | -69% |
Returns for 3 years | 64.76 | 13.97 | 464% |
Returns for 5 years | 30.67 | -24.58 | -125% |
Returns for 10 years | 80.65 | 1.52 | 5,293% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JAGLX | 75.17 | 0.46 | +0.62% |
Janus Henderson Global Life Sciences T | |||
SSCOX | 6.15 | 0.03 | +0.49% |
Touchstone Small Company C | |||
GMVIX | 16.67 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity Inv | |||
ABALX | 39.02 | 0.05 | +0.13% |
American Funds American Balanced A | |||
SGQIX | 46.28 | -0.03 | -0.06% |
DWS International Growth Inst |